The Taaneh solution

Following a detailed analysis of the current and pending requirements in authentication technology in the US and in global markets, Taaneh has identified a solution that delivers the precise capabilities industry needs to address counterfeiting challenges effectively at every stage in a product’s supply chain: diamond.

Diamond lattices possess variations in structure.

Diamond is a specific allotrope of carbon. It is comprised of two closely packed interpenetrating face-centered cubic lattices, with each lattice offset from the other by a quarter of its distance along the diagonal. Despite this uniformity, the lattices can possess variations in structure that make them unique, and when exposed to light they will emit spectral signatures belonging to them alone, creating a distinct birthmark of sorts. The variations in these spectral signatures are limitless.

The properties of diamond nanoparticles are clearly demonstrated and extensively supported in the literature. As a material, it is shown to be fully inert. Carbon is included on the FDA’s list of inactive ingredients in approved drug products. It offers proven stability and broad applicability. It can also support almost unlimited options in encryption, remotely programmable authentication, and use of secure databases to support verification and reporting as needed. And it can achieve these goals at low cost and with only minor modifications to manufacturing and labeling processes. It is as easy to employ as it is difficult to decrypt.

Taaneh – Delivering a New Standard in Authentication Technology

The Taaneh authentication technology platform based on the use of diamond particles - an inert indicia difficult or impossible to replicate - delivers all of these advantages:

  • An authentication solution customizable to address industry needs seamlessly.
  • Encryption that is widely variable and controllable, giving every product/batch unique coding with hundreds of thousands of encrypted signatures possible
  • Results achievable based on very low concentrations of diamond.
  • Easily incorporated into established manufacturing protocols and equipment.
  • Verification achievable instantly and remotely; immediate ability to link product to label at any time.
  • Product can be directly authenticated both before and after removal from package, including the ability to confirm authenticity through opaque packaging.
  • Supports authentication in overt, semi-covert, fully covert and forensic basis.
  • Limited risk of settling; blends easily into any formulations and to all labeling and printing options.
  • Low cost.
  • Applications beyond pharmaceuticals, including cosmetics and fragrances, foods, textiles, paint, ink, currency, mechanical components, electronics and packaging.
  • The opportunity to be used in ink and labeling with no risk of clogging or major modifications in production.
  • The solution described for pharmaceuticals is readily transferable to other industries.

Verification can be accomplished via a hand held, remotely programmable detection device that can be used at any point in the distribution chain. Spectra recorded from the finished product, uniquely identifying its lot and expiration date can be sent to, and maintained in, a secure database. In this example, the spectra are assigned an alpha identifier. Using a handheld detector that can be programmed through a secure network, the spectrum of the product is compared to the spectrum assigned to the product lot in the database. Moreover, the product package identifier – or any printing on the package – can be printed with ink containing the same random mixture of diamond as the drug product, inextricably linking the product to the package.